• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Photodynamic Therapy Market

    ID: MRFR/HC/41527-HCR
    200 Pages
    Garvit Vyas
    October 2025

    Photodynamic Therapy Market Research Report By Application (Oncology, Dermatology, Cardiology, Dentistry), By Type (Photosensitizing Agents, Light Sources, Lasers), By End User (Hospitals, Clinics, Research Institutions), By Technology (Laser Phototherapy, Non-Laser Light Phototherapy, PDT with Combination Therapy) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Photodynamic Therapy Market Infographic
    Purchase Options

    Photodynamic Therapy Market Summary

    As per MRFR analysis, the Photodynamic Therapy Market Size was estimated at 1.78 USD Billion in 2024. The Photodynamic Therapy industry is projected to grow from 1.974 USD Billion in 2025 to 5.544 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.88 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Photodynamic Therapy Market is poised for substantial growth driven by technological advancements and increasing demand for personalized treatment.

    • Technological advancements in photodynamic therapy are enhancing treatment efficacy and patient outcomes.
    • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector.
    • Oncology is the largest segment, whereas dermatology is witnessing the fastest growth due to rising skin cancer awareness.
    • The rising incidence of cancer and the growing demand for minimally invasive procedures are key drivers propelling market expansion.

    Market Size & Forecast

    2024 Market Size 1.78 (USD Billion)
    2035 Market Size 5.544 (USD Billion)
    CAGR (2025 - 2035) 10.88%

    Major Players

    Photocure ASA (NO), Galderma S.A. (CH), Merck & Co., Inc. (US), DUSA Pharmaceuticals, Inc. (US), Sensus Healthcare, Inc. (US), Aduro Biotech, Inc. (US), OncoSec Medical Incorporated (US), Curelight Ltd. (IL)

    Photodynamic Therapy Market Trends

    The Photodynamic Therapy Market is currently experiencing a notable evolution, driven by advancements in technology and an increasing understanding of the therapeutic potential of light-sensitive compounds. This innovative treatment modality, which utilizes light to activate photosensitizing agents, is gaining traction across various medical fields, including oncology, dermatology, and ophthalmology. The growing prevalence of chronic diseases and skin disorders is likely to propel demand for effective and minimally invasive treatment options. Furthermore, ongoing research and development efforts are expected to enhance the efficacy and safety profiles of photodynamic therapy, thereby broadening its application scope. In addition, the Photodynamic Therapy Market is witnessing a shift towards personalized medicine, where treatments are tailored to individual patient needs. This trend is indicative of a broader movement within healthcare, emphasizing the importance of customized therapeutic approaches. As healthcare providers increasingly adopt photodynamic therapy, the integration of advanced imaging techniques and real-time monitoring systems may further optimize treatment outcomes. Overall, the Photodynamic Therapy Market appears poised for growth, with a focus on innovation and patient-centered care likely to shape its future trajectory.

    Technological Advancements

    Recent innovations in light delivery systems and photosensitizers are enhancing the effectiveness of photodynamic therapy. These advancements may lead to improved treatment outcomes and expanded applications in various medical fields.

    Personalized Treatment Approaches

    The trend towards personalized medicine is influencing the Photodynamic Therapy Market, as healthcare providers seek to tailor treatments to individual patient profiles. This shift could enhance therapeutic efficacy and patient satisfaction.

    Increased Awareness and Acceptance

    Growing awareness among healthcare professionals and patients regarding the benefits of photodynamic therapy is likely to drive market growth. As acceptance increases, more practitioners may incorporate this modality into their treatment regimens.

    The global photodynamic therapy market is poised for expansion, driven by advancements in technology and increasing applications in oncology and dermatology, suggesting a transformative shift in treatment paradigms.

    National Institutes of Health

    Photodynamic Therapy Market Drivers

    Rising Incidence of Cancer

    The increasing prevalence of cancer worldwide is a primary driver for the Photodynamic Therapy Market. As cancer cases rise, the demand for effective treatment options escalates. According to recent statistics, cancer is projected to affect millions annually, leading to a surge in the need for innovative therapies. Photodynamic therapy, known for its targeted approach and minimal side effects, is gaining traction among healthcare providers. This trend is likely to continue, as patients and practitioners seek alternatives to traditional treatments. The Photodynamic Therapy Market is expected to expand significantly, driven by the urgent need for effective cancer management solutions.

    Regulatory Support and Approval

    Regulatory bodies are increasingly recognizing the potential of photodynamic therapy, which is fostering growth in the Photodynamic Therapy Market. Recent approvals of new photodynamic agents and treatment protocols by health authorities indicate a supportive regulatory environment. This trend encourages manufacturers to invest in the development of novel therapies, knowing that there is a pathway for approval. Furthermore, favorable reimbursement policies for photodynamic therapy treatments are likely to enhance accessibility for patients. As regulatory support continues to strengthen, the Photodynamic Therapy Market is expected to flourish.

    Increased Research and Development Activities

    The surge in research and development activities within the medical field is a notable driver for the Photodynamic Therapy Market. Numerous studies are being conducted to explore the potential applications of photodynamic therapy beyond oncology, including dermatology and ophthalmology. This expansion into new therapeutic areas could broaden the market's scope and attract a diverse patient population. Additionally, funding from governmental and private sectors for innovative treatment research is likely to enhance the development of new photodynamic agents and techniques. As R&D efforts intensify, the Photodynamic Therapy Market may experience accelerated growth.

    Growing Demand for Minimally Invasive Procedures

    The shift towards minimally invasive treatment options is significantly influencing the Photodynamic Therapy Market. Patients increasingly prefer therapies that offer reduced recovery times and lower risks of complications. Photodynamic therapy aligns with this trend, as it typically involves less invasive procedures compared to traditional surgical methods. This preference is reflected in patient choices and healthcare provider recommendations, leading to a rise in the adoption of photodynamic therapy for various conditions. As awareness of the benefits of minimally invasive treatments continues to grow, the Photodynamic Therapy Market is poised for substantial growth.

    Technological Innovations in Photodynamic Therapy

    Technological advancements play a crucial role in shaping the Photodynamic Therapy Market. Innovations in light delivery systems, photosensitizers, and imaging techniques enhance the efficacy and safety of photodynamic therapy. For instance, the development of new photosensitizers that are more effective at lower doses could potentially improve patient outcomes. Furthermore, advancements in laser technology allow for more precise targeting of tumors, minimizing damage to surrounding healthy tissues. As these technologies evolve, they are likely to attract more investment and research, thereby propelling the growth of the Photodynamic Therapy Market.

    Market Segment Insights

    By Application: Oncology (Largest) vs. Dermatology (Fastest-Growing)

    The Photodynamic Therapy Market is significantly influenced by its application segments, notably Oncology, Dermatology, Cardiology, and Dentistry. Oncology holds the largest share, leveraging advanced light-based therapies for cancer treatment, which showcases its established presence and trusted efficacy. Meanwhile, Dermatology follows with considerable prominence, employing photodynamic therapy for skin conditions like acne, actinic keratosis, and basal cell carcinoma, thus capturing substantial market interest.

    Oncology (Dominant) vs. Dermatology (Emerging)

    Oncology remains the dominant segment in the Photodynamic Therapy Market, characterized by its comprehensive use in treating various cancers through targeted light-activated drugs. The therapies are favored for their precision, minimizing damage to surrounding healthy tissues and maximizing treatment efficacy. Conversely, Dermatology is emerging rapidly, driven by increasing awareness and acceptance of photodynamic treatments for skin disorders. The segment's growth is bolstered by innovations in light delivery systems and novel photosensitizers, enhancing patient outcomes and leading to a broader adoption of these therapies in both clinical and cosmetic practices.

    By Type: Photosensitizing Agents (Largest) vs. Light Sources (Fastest-Growing)

    In the Photodynamic Therapy Market, the Type segment is primarily dominated by Photosensitizing Agents, which constitute the largest share of the market. These agents are crucial as they absorb light and initiate the therapeutic action against target tissues, leading to significant clinical outcomes. Following closely are Light Sources, which are experiencing rapid adoption due to technological advancements and increasing demand for minimally invasive procedures.

    Photosensitizing Agents (Dominant) vs. Light Sources (Emerging)

    Photosensitizing Agents play a dominant role in the Photodynamic Therapy Market due to their critical function in activating photodynamic therapy treatments. They are essential for ensuring effective targeting and destruction of tumors or abnormal tissue. On the other hand, Light Sources are emerging as a vital component, experiencing rapid growth driven by advancements in laser technology and heightened awareness of photodynamic therapy benefits. These sources enable precise targeting and improved patient outcomes, thus driving their quick adoption in clinical settings.

    By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

    In the Photodynamic Therapy Market, hospitals currently dominate the end-user segment, reflecting their significant role in advanced healthcare delivery and treatment of conditions such as cancer and skin disorders. Clinics, however, are emerging as a vital component of this market, gaining traction due to the rise in outpatient procedures and the increasing preference for less invasive treatment options among patients. As the demand for more accessible healthcare solutions grows, clinics are experiencing the fastest growth in this segment. Factors driving this trend include advancements in photodynamic therapy technologies, the increase in patient awareness of treatment options, and the shifting focus towards personalized medicine, which is prompting more patients to seek treatment in outpatient settings.

    Hospitals (Dominant) vs. Research Institutions (Emerging)

    Hospitals are the dominant end user in the Photodynamic Therapy Market, primarily due to their ability to provide comprehensive treatment options, including surgical and oncological procedures. They offer state-of-the-art facilities and specialized medical staff, enabling them to deliver advanced therapies effectively. This strong market position is bolstered by hospitals’ extensive patient networks and collaborations with pharmaceutical companies. On the other hand, research institutions are emerging as a critical player in the market, focused on developing innovative photodynamic therapy applications and conducting clinical trials. Their role is pivotal in advancing the scientific understanding of photodynamic therapy, potentially leading to new treatment protocols and greater acceptance in clinical practices.

    By Technology: Laser Phototherapy (Largest) vs. Non-Laser Light Phototherapy (Fastest-Growing)

    The Photodynamic Therapy Market is notably segmented by technology, with Laser Phototherapy dominating the market. This segment has established itself as a trusted modality in various applications, making it the largest contributor to market share. Its precision and efficacy in targeting tissues with minimal damage have propelled its widespread adoption and recognition among healthcare professionals. In contrast, Non-Laser Light Phototherapy is gaining momentum, appealing to a newer demographic drawn to its versatile applications and non-invasive nature. This segment has witnessed accelerated uptake, reflecting the evolving preferences of patients seeking alternative treatment modalities. Growth trends in the Photodynamic Therapy market reveal that advancements in technology and increased awareness about phototherapy have stimulated an upward growth trajectory. The rise in chronic conditions requiring effective therapeutic solutions has also contributed significantly to market expansion. Healthcare professionals are increasingly incorporating both Laser and Non-Laser light modalities into treatment protocols, driven by favorable patient outcomes. The focus on research and development for new treatments presents robust opportunities for further growth amid changing healthcare dynamics.

    Technology: Laser Phototherapy (Dominant) vs. Non-Laser Light Phototherapy (Emerging)

    Laser Phototherapy stands as the dominant technology in the Photodynamic Therapy Market, characterized by its precision in delivering light energy and its authority in treating conditions like cancer and skin disorders. The high efficacy and targeted nature of laser systems ensure minimal collateral damage, bolstering clinician confidence and patient outcomes. Meanwhile, Non-Laser Light Phototherapy is quickly emerging, known for its accessibility and adaptability across diverse treatments. This segment appeals to a broad audience, including those deterred by invasive procedures. Its continued development and increasing recognition among practitioners signify a growing inclination towards its integration into treatment paradigms, thus reshaping the competitive landscape of the market.

    Get more detailed insights about Photodynamic Therapy Market

    Regional Insights

    North America holds a significant portion, valued at 0.75 USD Billion, and is projected to dominate with an expected value of 2.35 USD Billion in 2035, driven by advanced healthcare infrastructure and high adoption of innovative therapies. Europe follows with a valuation of 0.5 USD Billion in 2024, anticipated to reach 1.6 USD Billion by 2035, reflecting a robust market growth fueled by increased awareness and technological advancements.

    The APAC region, valued at 0.4 USD Billion in 2024 and expected to grow to 1.25 USD Billion by 2035, is becoming increasingly important due to rising demand for cost-effective treatment options and improved healthcare access. South America and MEA, while smaller markets valued at 0.08 USD Billion and 0.05 USD Billion respectively in 2024 are poised for growth as healthcare systems evolve and access to treatments expands, though they currently contribute less to the overall market.

    The competitive landscape and market growth are significantly influenced by the varying healthcare policies, economic conditions, and uptake of photodynamic therapy advancements across these regions.

    Photodynamic Therapy Market Region

    Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

    Key Players and Competitive Insights

    The Global Photodynamic Therapy Market has demonstrated robust growth driven by advancements in technology, increasing healthcare expenditures, and an expanding range of applications in treating various conditions including cancer, macular degeneration and skin disorders. As more healthcare providers adopt photodynamic therapy due to its minimally invasive nature and effective treatment outcomes, competition among players in this sector has intensified. Companies are strategically positioning themselves by innovating product pipelines, forming partnerships, and enhancing their distribution networks to capture market share.

    The increasing prevalence of chronic diseases and the rising demand for outpatient therapies further contribute to the competitive dynamics that define this evolving market landscape.

    Lumenis stands out in the Global Photodynamic Therapy Market by leveraging its strong technological capabilities and a diverse portfolio of advanced systems that utilize precisely controlled light for therapeutic purposes. Known for its extensive experience and expertise in energy-based technologies, Lumenis has established a significant presence, particularly in non-invasive treatments. The company’s commitment to research and development is noteworthy, as it continuously innovates its offerings to integrate new features that enhance treatment effectiveness and patient safety.

    With a strong focus on clinical data and user feedback, Lumenis maintains its competitive advantage by ensuring its products meet the rigorous demands of healthcare providers and patients alike.

    ConvaTec has made substantial contributions within the Global Photodynamic Therapy Market, focusing on developing innovative solutions that cater to specific therapeutic needs. The company emphasizes a patient-centered approach, concentrating on improving treatment outcomes and enhancing patient quality of life. ConvaTec’s product development is characterized by strategic initiatives aimed at combining advanced technology with practical application to address market gaps. Their strong reputation in medical devices, combined with robust regulatory compliance and quality management systems, positions ConvaTec favorably in the competitive landscape.

    By fostering collaborations with healthcare professionals and institutions, the company aims to expand its market reach and reinforce its presence in the photodynamic therapy segment.

    Key Companies in the Photodynamic Therapy Market market include

    Industry Developments

    • Q2 2024: Biofrontera Inc. Announces FDA Approval of Ameluz® for Expanded Indication in Photodynamic Therapy Biofrontera Inc. received FDA approval to expand the indication of its Ameluz® gel for use in photodynamic therapy, allowing treatment of actinic keratosis on the extremities and trunk in addition to the face and scalp.
    • Q2 2024: Lumeda Announces $6 Million Series A Financing to Advance Photodynamic Therapy Platform Lumeda, a company developing next-generation photodynamic therapy solutions for lung cancer, closed a $6 million Series A funding round to support clinical development and commercialization efforts.
    • Q2 2024: Soligenix Announces Positive Results from Phase 3 FLASH Study of SGX301 in Cutaneous T-Cell Lymphoma Soligenix reported positive topline results from its Phase 3 FLASH study evaluating SGX301, a novel photodynamic therapy, for the treatment of cutaneous T-cell lymphoma, supporting a future regulatory submission.
    • Q3 2024: Biofrontera Inc. Appoints New Chief Executive Officer Biofrontera Inc., a key player in the photodynamic therapy market, announced the appointment of a new CEO to lead the company’s next phase of growth and product expansion.
    • Q3 2024: Lumeda and Mayo Clinic Announce Strategic Collaboration to Advance Photodynamic Therapy for Lung Cancer Lumeda entered into a strategic collaboration with Mayo Clinic to accelerate the development and clinical validation of its photodynamic therapy platform for lung cancer treatment.
    • Q4 2024: Biofrontera Inc. Opens New Manufacturing Facility in the United States Biofrontera Inc. inaugurated a new manufacturing facility in the U.S. to increase production capacity for its photodynamic therapy products, supporting growing demand in North America.
    • Q1 2025: Soligenix Submits New Drug Application to FDA for SGX301 in Cutaneous T-Cell Lymphoma Soligenix submitted a New Drug Application to the FDA for SGX301, seeking approval for its photodynamic therapy in the treatment of cutaneous T-cell lymphoma.
    • Q1 2025: Lumeda Receives Breakthrough Device Designation from FDA for Photodynamic Therapy System Lumeda was granted Breakthrough Device Designation by the FDA for its photodynamic therapy system, designed to improve outcomes in lung cancer patients.
    • Q2 2025: Biofrontera Inc. Announces Partnership with Cardinal Health for U.S. Distribution of Ameluz® Biofrontera Inc. entered into a distribution agreement with Cardinal Health to expand the reach of its Ameluz® photodynamic therapy gel across the United States.
    • Q2 2025: Soligenix Receives European Medicines Agency Orphan Drug Designation for SGX301 Soligenix was granted Orphan Drug Designation by the European Medicines Agency for SGX301, its photodynamic therapy candidate for cutaneous T-cell lymphoma.

    Future Outlook

    Photodynamic Therapy Market Future Outlook

    The Photodynamic Therapy Market is projected to grow at a 10.88% CAGR from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising healthcare expenditure.

    New opportunities lie in:

    • Development of targeted photodynamic agents for specific cancer types.
    • Expansion of telemedicine platforms for remote photodynamic therapy consultations.
    • Partnerships with healthcare providers for integrated photodynamic therapy services.

    By 2035, the Photodynamic Therapy Market is expected to achieve substantial growth and innovation.

    Market Segmentation

    Photodynamic Therapy Market Type Outlook

    • Photosensitizing Agents
    • Light Sources
    • Lasers

    Photodynamic Therapy Market End User Outlook

    • Hospitals
    • Clinics
    • Research Institutions

    Photodynamic Therapy Market Technology Outlook

    • Laser Phototherapy
    • Non-Laser Light Phototherapy
    • PDT with Combination Therapy

    Photodynamic Therapy Market Application Outlook

    • Oncology
    • Dermatology
    • Cardiology
    • Dentistry

    Report Scope

    MARKET SIZE 20241.78(USD Billion)
    MARKET SIZE 20251.974(USD Billion)
    MARKET SIZE 20355.544(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)10.88% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in light-activated agents enhance efficacy in the Photodynamic Therapy Market.
    Key Market DynamicsRising demand for minimally invasive treatments drives innovation and competition in the Photodynamic Therapy Market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the expected market size of the Global Photodynamic Therapy Market by 2024?

    The Global Photodynamic Therapy Market is expected to be valued at 1.78 USD Billion in 2024.

    What is the projected market size for the Global Photodynamic Therapy Market by 2035?

    By 2035, the Global Photodynamic Therapy Market is projected to reach a value of 5.53 USD Billion.

    What is the expected CAGR for the Global Photodynamic Therapy Market from 2025 to 2035?

    The expected CAGR for the Global Photodynamic Therapy Market from 2025 to 2035 is 10.88%.

    Which region is expected to have the largest market share in 2035?

    North America is expected to have the largest market share, projected to reach 2.35 USD Billion in 2035.

    What will be the market value of the Oncology application segment in 2035?

    The Oncology application segment is expected to reach a market value of 2.8 USD Billion in 2035.

    Which are the key players operating in the Global Photodynamic Therapy Market?

    Major players in the Global Photodynamic Therapy Market include Lumenis, ConvaTec, Biolitec AG, Merck KGaA as well as others.

    What is the anticipated market value for Dermatology applications by 2035?

    The market value for Dermatology applications is anticipated to reach 1.2 USD Billion by 2035.

    What is the projected market size for the Cardiology application in 2035?

    The market size for Cardiology applications is projected to be 0.75 USD Billion in 2035.

    How much will the South American market be valued at by 2035?

    The South American market is expected to be valued at 0.25 USD Billion in 2035.

    What is the anticipated market value for Dentistry applications by 2035?

    The anticipated market value for Dentistry applications is expected to reach 0.78 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions